166 related articles for article (PubMed ID: 30799835)
21. Novel Approaches Reveal that Toxoplasma gondii Bradyzoites within Tissue Cysts Are Dynamic and Replicating Entities In Vivo.
Watts E; Zhao Y; Dhara A; Eller B; Patwardhan A; Sinai AP
mBio; 2015 Sep; 6(5):e01155-15. PubMed ID: 26350965
[TBL] [Abstract][Full Text] [Related]
22. The apicoplast is important for the viability and persistence of
Sanchez SG; Bassot E; Cerutti A; Mai Nguyen H; Aïda A; Blanchard N; Besteiro S
Proc Natl Acad Sci U S A; 2023 Aug; 120(34):e2309043120. PubMed ID: 37590416
[No Abstract] [Full Text] [Related]
23. Toxoplasma gondii reorganizes the host cell architecture during spontaneous cyst formation in vitro.
Paredes-Santos TC; Martins-Duarte ES; de Souza W; Attias M; Vommaro RC
Parasitology; 2018 Jul; 145(8):1027-1038. PubMed ID: 29179785
[TBL] [Abstract][Full Text] [Related]
24. A cell culture system for study of the development of Toxoplasma gondii bradyzoites.
Weiss LM; Laplace D; Takvorian PM; Tanowitz HB; Cali A; Wittner M
J Eukaryot Microbiol; 1995; 42(2):150-7. PubMed ID: 7757057
[TBL] [Abstract][Full Text] [Related]
25. Chitosan and silver nanoparticles: promising anti-toxoplasma agents.
Gaafar MR; Mady RF; Diab RG; Shalaby TI
Exp Parasitol; 2014 Aug; 143():30-8. PubMed ID: 24852215
[TBL] [Abstract][Full Text] [Related]
26. Primary skeletal muscle cells trigger spontaneous Toxoplasma gondii tachyzoite-to-bradyzoite conversion at higher rates than fibroblasts.
Ferreira-da-Silva Mda F; Takács AC; Barbosa HS; Gross U; Lüder CG
Int J Med Microbiol; 2009 Jun; 299(5):381-8. PubMed ID: 19097936
[TBL] [Abstract][Full Text] [Related]
27. In vitro activity of N-phenyl-1,10-phenanthroline-2-amines against tachyzoites and bradyzoites of Toxoplasma gondii.
Martins-Duarte ES; Portes JA; da Silva RB; Pires HS; Garden SJ; de Souza W
Bioorg Med Chem; 2021 Nov; 50():116467. PubMed ID: 34666274
[TBL] [Abstract][Full Text] [Related]
28. Toxoplasma gondii in primary rat CNS cells: differential contribution of neurons, astrocytes, and microglial cells for the intracerebral development and stage differentiation.
Lüder CG; Giraldo-Velásquez M; Sendtner M; Gross U
Exp Parasitol; 1999 Sep; 93(1):23-32. PubMed ID: 10464035
[TBL] [Abstract][Full Text] [Related]
29. Bradyzoite-induced murine toxoplasmosis: stage conversion, pathogenesis, and tissue cyst formation in mice fed bradyzoites of different strains of Toxoplasma gondii.
Dubey JP
J Eukaryot Microbiol; 1997; 44(6):592-602. PubMed ID: 9435131
[TBL] [Abstract][Full Text] [Related]
30. Activity of the histone deacetylase inhibitor FR235222 on Toxoplasma gondii: inhibition of stage conversion of the parasite cyst form and study of new derivative compounds.
Maubon D; Bougdour A; Wong YS; Brenier-Pinchart MP; Curt A; Hakimi MA; Pelloux H
Antimicrob Agents Chemother; 2010 Nov; 54(11):4843-50. PubMed ID: 20713670
[TBL] [Abstract][Full Text] [Related]
31. The development and biology of bradyzoites of Toxoplasma gondii.
Weiss LM; Kim K
Front Biosci; 2000 Apr; 5():D391-405. PubMed ID: 10762601
[TBL] [Abstract][Full Text] [Related]
32. Stress-related and spontaneous stage differentiation of Toxoplasma gondii.
Ferreira da Silva Mda F; Barbosa HS; Gross U; Lüder CG
Mol Biosyst; 2008 Aug; 4(8):824-34. PubMed ID: 18633484
[TBL] [Abstract][Full Text] [Related]
33. Unexpected oocyst shedding by cats fed Toxoplasma gondii tachyzoites: in vivo stage conversion and strain variation.
Dubey JP
Vet Parasitol; 2005 Nov; 133(4):289-98. PubMed ID: 16024176
[TBL] [Abstract][Full Text] [Related]
34. Infection with Toxoplasma gondii bradyzoites has a diminished impact on host transcript levels relative to tachyzoite infection.
Fouts AE; Boothroyd JC
Infect Immun; 2007 Feb; 75(2):634-42. PubMed ID: 17088349
[TBL] [Abstract][Full Text] [Related]
35. Toxoplasma gondii Hsp90 is a potential drug target whose expression and subcellular localization are developmentally regulated.
Echeverria PC; Matrajt M; Harb OS; Zappia MP; Costas MA; Roos DS; Dubremetz JF; Angel SO
J Mol Biol; 2005 Jul; 350(4):723-34. PubMed ID: 15967463
[TBL] [Abstract][Full Text] [Related]
36. The differential expression of multiple isoenzyme forms during stage conversion of Toxoplasma gondii: an adaptive developmental strategy.
Tomavo S
Int J Parasitol; 2001 Aug; 31(10):1023-31. PubMed ID: 11429165
[TBL] [Abstract][Full Text] [Related]
37. Starch Branching Enzyme 1 Is Important for Amylopectin Synthesis and Cyst Reactivation in Toxoplasma gondii.
Yang J; He Z; Chen C; Zhao J; Fang R
Microbiol Spectr; 2022 Jun; 10(3):e0189121. PubMed ID: 35446124
[TBL] [Abstract][Full Text] [Related]
38. Toxoplasma gondii: Bradyzoite Differentiation In Vitro and In Vivo.
Mayoral J; Di Cristina M; Carruthers VB; Weiss LM
Methods Mol Biol; 2020; 2071():269-282. PubMed ID: 31758458
[TBL] [Abstract][Full Text] [Related]
39. A novel rhoptry protein in Toxoplasma gondii bradyzoites and merozoites.
Schwarz JA; Fouts AE; Cummings CA; Ferguson DJ; Boothroyd JC
Mol Biochem Parasitol; 2005 Dec; 144(2):159-66. PubMed ID: 16182390
[TBL] [Abstract][Full Text] [Related]
40. Toxoplasma gondii: kinetics of bradyzoite-tachyzoite interconversion in vitro.
Soete M; Fortier B; Camus D; Dubremetz JF
Exp Parasitol; 1993 May; 76(3):259-64. PubMed ID: 7684705
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
